Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Randomized, Double-Blind, Active-Controlled Trial of Every-3-Week Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia
2006·104 Zitationen·JNCI Journal of the National Cancer InstituteOpen Access
Volltext beim Verlag öffnen104
Zitationen
8
Autoren
2006
Jahr
Abstract
Patients with chemotherapy-induced anemia can safely and effectively be treated with 500 microg of darbepoetin alfa every 3 weeks.
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 22.003 Zit.
Anemia of Chronic Disease
2005 · 3.696 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.731 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.167 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.088 Zit.
Autoren
Institutionen
Themen
Erythropoietin and Anemia TreatmentIron Metabolism and DisordersArtificial Intelligence in Healthcare and Education